Cite

HARVARD Citation

    Mammen, A. et al. (2023). Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial. Lancet. pp. e67-e76. [Online]. 
  
Back to record